Bilcare - About the company
Bilcare is an acquired company based in Pune (India), founded in 1993 by Mohan Bhandari and Wolfgang Beck. It operates as a Company offering innovative solutions for pharma packaging, clinical supplies and anti-counterfeiting. Bilcare has raised an undisclosed amount in funding. The company has 935 active competitors, including 32 funded and 147 that have exited. Its top competitors include companies like West Pharmaceutical Services, Gerresheimer and Nivagen Pharmaceuticals.
Company Details
Bilcare is a pharma packaging solutions provider. The company has 3 major divisions - Pharmaceutical Packaging International (PPI), Global Clinical Material Supplies (GCS) and non-clonable ID technologies. The PPI division offers packaging solutions mainly for solid dose packaging through specialty Polymer Films and Aluminum Foils. The GCS division offers clinical trial supply management services such as clinical supplies packaging and labelling, controlled-temperature (cold chain) CTM storage, worldwide distribution and returns and destructions accountability etc. The non-clonable ID technologies division offers track and trace, authentication and Anti-counterfeit (trademarked nCID technology - nonclonableID) solutions for product; people ID authentication and security. The company has 9 manufacturing facilities spread across Europe, US and Asia. Bilcare's clientele includes Bristol-Myers Squibb, Dr. Reddy’s, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Ranbaxy, Sanofi-Aventis, and Teva, among others.
- Website
- bilcare.com
- Email ID
- *****@bilcare.com
- Phone Number
- +91 **********
- Registered Address
- 1028 Shiroli, Rajgurunagar, Pune, Shiroli, Pune, Khed, Maharashtra, India, 410505
Key Metrics
Founded Year
1993
Location
Pune, India
Stage
Acquired
Latest Funding Round
Investors
Ranked
27th among 935 active competitors
Annual Revenue
₹500 - ₹1,000 Cr as on Mar 31, 2025
Employee Count
283 as on Oct 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by Lindsay Goldberg (Sep 04, 2019)
Legal entities associated with Bilcare
Bilcare is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
BILCARE GCS LIMITED CIN: 9521655 , United Kingdom, Deadpooled | Mar 31, 2015 | £0 - £1M (As on Mar 31, 2024) | - | |
CAPRIHANS INDIA LIMITED CIN: L29150PN1946PLC232362 , India, Active | Apr 11, 1946 | ₹500 - ₹1,000 Cr (As on Mar 31, 2025) | 505 (As on Apr 30, 2025) | |
BILCARE LIMITED CIN: L28939PN1987PLC043953 , India, Active | Jul 01, 1987 | ₹500 - ₹1,000 Cr (As on Mar 31, 2025) | 75 (As on Nov 30, 2024) | |
BILCARE RESEARCH, INC. CIN: 383655283 , United States, Active | Dec 31, 1999 | - | 68 (As on Dec 31, 2024) | - |
Bilcare's acquisition details
Bilcare got acquired by Lindsay Goldberg on Sep 04, 2019.
Click here to take a look at Bilcare's acquisition in detail
Sign up to download Bilcare's company profile
Bilcare's funding and investors
Bilcare has raised funding over 2 rounds. Its first funding round was on Feb 22, 2010. Its latest funding round was a Conventional Debt round on Aug 27, 2014 for $*****. 1 investor participated in its latest round. Bilcare has 3 institutional investors.
Here is the list of recent funding rounds of Bilcare:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 27, 2014 | 3836957 | Conventional Debt | 2374128 | 7201171 | 7097062 | 8054851 |
Feb 22, 2010 | 8098215 | Post IPO | 6478539 | 1917483 | 3692059 |
View details of Bilcare's funding rounds and investors
Bilcare's founders and board of directors
Founder? Claim ProfileHere are the details of Bilcare's key team members:
- Mohan Bhandari: Founder & CEO of Bilcare. They serve on the board of 1 company.Contact Info: 1 email address
- Wolfgang Beck: Founder of Bilcare.
Bilcare's Board of Directors
Bilcare's board has 6 active members. Mohan Bhandari is part of team and Kavita Bhansali, Rajesh Shankarrao Devene, Abhigyan Upadhyay, Alka Sagar and Madhuri Rajan Vaidya are independent board members.Here is the list of Bilcare's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 4y 4m | |
Independent board member | - | Current | 3y 2m | |
w{tyhch | Independent board member | - | Current | 5y 6m |
omyfccd | Independent board member | - | Current | 7y 5m |
npyliwd | Independent board member | - | Current | 4y 8m |
ivqqwcn | Independent board member | - | Current | 8y 8m |
View details of Bilcare's Founder profiles and Board Members
Bilcare's employee count trend
Bilcare has 283 employees as of Oct 26. Here is Bilcare's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bilcare's Competitors and alternates
Top competitors of Bilcare include West Pharmaceutical Services, Gerresheimer and Nivagen Pharmaceuticals. Here is the list of Top 10 competitors of Bilcare, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | West Pharmaceutical Services 1923, Exton (United States), Public | Manufacturer of traditional packaging, containment, and delivery solutions for injectables | - | - | 66/100 |
2nd | Gerresheimer 1864, Dusseldorf (Germany), Acquired | Manufacturer of primary packaging products for medication and drug delivery devices | - | 65/100 | |
3rd | Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired | Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution | $31M | 60/100 | |
4th | Jubilant Life Sciences 1978, Noida (India), Public | Company offering a suite of R&D and manufacturing services for small molecules and generics | - | 59/100 | |
5th | Provider of regulatory affair, quality control, and market strategy services to biopharma sector | $13M | 59/100 | ||
6th | Manufacturer & supplier of solid dosage products, pharmaceutical machinery and equipment, and packaging solutions | - | 58/100 | ||
7th | Asahi Kasei 1931, Chiyoda-ku (Japan), Public | CDMO focused on manufacturing of liquid, solid & injectable drug formulations | - | 55/100 | |
8th | Contract development and manufacturing organization for proprietary and generic drugs | - | 54/100 | ||
9th | Contract laboratory and contract manufacturing services for pharmaceutical and animal health industries | - | - | 54/100 | |
10th | Developer of proprietary stabilizing and protecting solutions for biologics formulation | $17.5M | 54/100 | ||
27th | Company offering innovative solutions for pharma packaging, clinical supplies and anti-counterfeiting | - | 50/100 |
Looking for more details on Bilcare's competitors? Click here to see the top ones
Financials of BilcareFY 25 Available
CAPRIHANS INDIA LIMITED, the legal entity associated with Bilcare, generated between ₹500 Cr and ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of CAPRIHANS INDIA LIMITED has a compounded annual growth rate (CAGR) of 6% in the last 1 year.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 2138 | 3486 | 4124 | 4085 | 3318 |
Total Sales | 9827 | 9481 | 2047 | 3252 | 5666 |
Total Expenses | 1507 | 5791 | 6484 | 1976 | 6375 |
Operating Expenses | 4205 | 8092 | 6850 | 9177 | 1984 |
Employee Expenses | 3171 | 3253 | 1657 | 5615 | 3114 |
Marketing Expenses | 2618 | 2638 | 4510 | 2266 | 5432 |
Operating Income (EBIT) | 8858 | 6876 | 4073 | 7698 | 2115 |
Interest Expenses | 8706 | 6348 | 6877 | 9768 | 9400 |
Expenses from other activities | 4178 | 9346 | 1402 | 8449 | 7865 |
EBITDA | 7986 | 5538 | 7568 | 5245 | 8179 |
Taxes | 4324 | 3119 | 9797 | 8033 | 1888 |
Net Profit | 4009 | 8533 | 8807 | 6230 | 6695 |
Balance Sheet | |||||
Assets | 6509 | 2386 | 7190 | 1617 | 1227 |
Cash Equivalent | 5859 | 6871 | 4043 | 8371 | 5547 |
Accounts Receivables | 2977 | 3462 | 8825 | 8845 | 3827 |
Inventory | 5150 | 2012 | 5250 | 6262 | 6523 |
Liabilities | 4169 | 3798 | 2012 | 1019 | 7666 |
Total Debt | 3992 | 1133 | 8439 | 9813 | 4926 |
Accounts Payable | 5877 | 4055 | 2551 | 2257 | 4300 |
Equities | 2328 | 2717 | 1367 | 9006 | 6883 |
Cashflow Statement | |||||
Cash from Operating activities | 4092 | 8907 | 5336 | 4483 | 9984 |
Cash from Investing activities | 4504 | 5741 | 1995 | 6837 | 8153 |
Net cash from Financing activities | 5136 | 1583 | 3732 | 7324 | 7616 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Bilcare's Investments and acquisitions
Bilcare has acquired Singular ID. Bilcare has not made any investments as of now.Reports related to Bilcare
Here is the latest report on Bilcare's sector:
News related to Bilcare
Media has covered Bilcare for 1 event in last 1 year, It was about company updates.
•
From College Student to Rs 800 Cr Pharma Chief: The Inspiring Journey of Vinay SapteIndiatimes•Aug 01, 2026•Bilcare
•
•
Bilcare Standalone June 2021 Net Sales at Rs 86.94 crore, up 19.51% Y-o-YMoneycontrol•Aug 11, 2021•Bilcare
•
•
Lindsay Goldberg acquires Bilcare ResearchUnquote•Nov 11, 2019•Lindsay Goldberg, Bilcare, Niederer Kraft Frey
•
Lindsay Goldberg to buy pharma packaging maker Bilcare ResearchReuters•Sep 04, 2019•Lindsay Goldberg, Bilcare, Swiss Pharma
•
•
•
Mitsui Chemicals in Collaboration with Bilcare Introduces Chemipearl™ XSP in India: Business Wire•Nov 20, 2017•Mitsui Chemicals, Bilcare
•
Are you a Founder ?
FAQs about Bilcare
Explore our recently published companies
- Kakoki - Japan based, 1964 founded, Public company
- Yarrow - Ashburn based, 2026 founded, Unfunded company
- mojaKsiegowa - Poznan based, 2026 founded, Unfunded company
- Montari - Apeldoorn based, 2026 founded, Unfunded company
- B2BEVENTJOBS - 2026 founded, Unfunded company
- Linko Tech - Richmond Hill based, 2026 founded, Unfunded company